These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 819062)

  • 21. Redistribution and modulation of Gross murine leukemia virus antigens induced by specific antibodies.
    Ioachim HL; Sabbath M
    J Natl Cancer Inst; 1979 Jan; 62(1):169-80. PubMed ID: 281570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. H-2-restricted cytolytic T lymphocytes specific for a subclass of AKR endogenous leukemia virus-induced tumors: correlation of tumor cell susceptibility with expression of the gross cell surface antigen.
    Green WR
    J Immunol; 1980 Dec; 125(6):2584-90. PubMed ID: 6159413
    [No Abstract]   [Full Text] [Related]  

  • 23. Wild-type Gross leukemia virus. I. Soluble antigen (GSA) in the plasma and tissues of infected mice.
    Aoki T; Boyse EA; Old LJ
    J Natl Cancer Inst; 1968 Jul; 41(1):89-96. PubMed ID: 4880891
    [No Abstract]   [Full Text] [Related]  

  • 24. Serological analysis of cell surface antigens of tumors induced by murine leukemia virus.
    Herberman RB
    J Natl Cancer Inst; 1972 Jan; 48(1):265-71. PubMed ID: 4119883
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of spontaneous leukemia in AKR mice with chemotherapy, immunotherapy, or interferon.
    Bekesi JG; Roboz JP; Zimmerman E; Holland JF
    Cancer Res; 1976 Feb; 36(2 pt 2):631-9. PubMed ID: 1082796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Adoptive immunotherapy of Gross virus-induced or-infected tumors in Gross tolerant rats (author's transl)].
    Takeichi N; Kuzumaki N; Kobayashi H
    Hokkaido Igaku Zasshi; 1974 May; 49(3):206-12. PubMed ID: 4480371
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunologic studies in virus-induced mouse and rat leukemia. II. Demonstration of a membrane-bound, group-specific leukemia antigen in Graffi and Gross leukemias of the mouse].
    Micheel B; Pasternak G; Bierwolf D
    Acta Biol Med Ger; 1972; 28(1):167-75. PubMed ID: 4114866
    [No Abstract]   [Full Text] [Related]  

  • 28. Lymphoma development from transplanted murine leukemia virus infected organ cultured thymuses: inhibitory effect of in vitro interferon treatment.
    Riesenfeld I; Tufveson G; Alm GV
    Int J Cancer; 1980 Apr; 25(4):529-34. PubMed ID: 6154660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presence of antibody against mouse fetal antigen in the sera from C57BL-6 mice immunized with Rauscher leukemia.
    Ishimoto A; Ito Y
    Cancer Res; 1972 Nov; 32(11):2332-7. PubMed ID: 4343227
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies of inhibition of tumour cell DNA synthesis by immune cells in Gross virus induced leukemia.
    Finklestein JZ; Byfield J; Tittle K; Imagawa DT
    Rev Eur Etud Clin Biol; 1972 Mar; 17(3):287-92. PubMed ID: 5053619
    [No Abstract]   [Full Text] [Related]  

  • 31. Molecular analysis of the cytolytic T-lymphocyte response elicited by retrovirus-induced tumours in mice.
    Plata F; Langlade-Demoyen P; Abastado JP; Berbar T; Kourilsky P
    Ann Inst Pasteur Immunol; 1986; 137D(3):409-12. PubMed ID: 3493789
    [No Abstract]   [Full Text] [Related]  

  • 32. A shift in the requirement for CD4+ T cells in the generation of AKR/Gross MuLV-specific CTL in AKR.H-2b:Fv-1b mice occurs prior to the onset of age-dependent CTL nonresponsiveness.
    Smith PM; Rich RF; Green WR
    Cell Immunol; 1997 Feb; 175(2):189-98. PubMed ID: 9023425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD4-CD8+ T lymphocytes mediate AKR/gross murine leukemia virus nonresponsiveness in moderately aged AKR.H-2b:Fv-1b mice.
    Rich RF; Fujii T; Green WR
    J Immunol; 1992 May; 148(9):2961-7. PubMed ID: 1349325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific antigenicity of tumors and immunological tolerance in the rat induced by Friend, Gross, and Rauscher viruses.
    Kobayashi H; Kuzumaki N; Gotoda E; Takeichi N; Sendo F
    Cancer Res; 1973 Jul; 33(7):1598-603. PubMed ID: 4124486
    [No Abstract]   [Full Text] [Related]  

  • 35. Common cell-surface antigen associated with murine and feline C-type RNA leukemia viruses.
    Yoshiki T; Mellors RC; Hardy WD
    Proc Natl Acad Sci U S A; 1973 Jun; 70(6):1878-82. PubMed ID: 4352660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liposomes as a tool to study the role of membrane presentation in the immunogenicity of a MuLV-related tumor antigen.
    Gerlier D; Bakouche O; Dore JF
    J Immunol; 1983 Jul; 131(1):485-90. PubMed ID: 6190925
    [No Abstract]   [Full Text] [Related]  

  • 37. Virus-coded antigens in chemically induced leukemia.
    Pasternak G; Pasternak L
    Boll Ist Sieroter Milan; 1971; 50(3):192-8. PubMed ID: 5004411
    [No Abstract]   [Full Text] [Related]  

  • 38. Alteration of skin in gross leukemia. V. Refutation of virus involvement.
    Mariani T; Maruyama Y
    J Natl Cancer Inst; 1974 Dec; 53(6):1661-4. PubMed ID: 4612164
    [No Abstract]   [Full Text] [Related]  

  • 39. T cells from naive mice suppress the in vitro cytotoxic response against endogenous Gross virus-induced tumor cells.
    Tilkin AF; Gomard E; Begue B; Levy JP
    J Immunol; 1984 Jan; 132(1):520-6. PubMed ID: 6228582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Demonstration of immunological differences between Graffi- and Gross-virus induced mouse leukemias in vivo and in vitro].
    Pasternak G; Hölzer B
    Neoplasma; 1965; 12(4):339-55. PubMed ID: 4285320
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.